Exon junction complexes (EJCs) are deposited onto mRNAs during splicing, serve as positional landmarks for the intron exon structure of genes, and direct posttranscriptional processes in the cytoplasm. EJC removal and recycling by translation are ill understood and have been attributed to ribosomal passage. This work identifies the ribosomeassociated protein PYM as an EJC disassembly factor and defines its mechanism of function. Whereas EJC assembly intermediates are resistant to PYM, fully assembled EJCs are dissociated from spliced mRNAs by PYM. This disassembly involves PYM binding to the EJC proteins MAGOH-Y14. PYM overexpression in cells disrupts EJC association with spliced mRNA and inhibits nonsense-mediated mRNA decay. In cells depleted of PYM, EJCs accumulate on spliced mRNAs and EJC protein recycling is impaired. Hence, PYM is an EJC disassembly factor that acts both in vitro and in living cells, and that antagonizes important EJC functions.
INTRODUCTION
Exon junction complexes (EJCs) are deposited by spliceosomes onto maturing mRNAs. They provide architectural information regarding the position of (former) introns to cytoplasmic processes like nonsense-mediated decay (NMD) that interprets such information to determine whether translational stop codons are physiological or premature (Maquat, 2004; Conti and Izaurralde, 2005; Chang et al., 2007) . In addition, EJCs can enhance mRNA export (Le Hir et al., 2001 ) and translation (Wiegand et al., 2003; Nott et al., 2004; Diem et al., 2007) , and they are necessary for correct oskar mRNA localization in Drosophila (Hachet and Ephrussi, 2004; Palacios et al., 2004) . Because the abundance of the EJC proteins eIF4A3, MAGOH, Y14, and BTZ in mammalian cells is limited and the number of exonexon junctions is high in the steady-state transcriptome, EJCs must be efficiently disassembled and recycled to ensure that maturing mRNAs can be appropriately tagged. According to current models, EJCs and associated factors are removed in the cytoplasm during the first round of translation if EJCs are located within the open reading frame (ORF) (Dostie and Dreyfuss, 2002; Lejeune et al., 2002) . This removal has been attributed to the processivity of the translating ribosome.
The protein PYM (WIBG) has been identified as an interaction partner of the MAGOH-Y14 heterodimer (Forler et al., 2003) , and the crystal structure of PYM in complex with showed that PYM binds the EJC proteins via its N-terminal region (Bono et al., 2004) . Based on its physical interaction with the EJC proteins and the finding that tethering of PYM to the 3 0 untranslated region (UTR) of a reporter mRNA diminishes its abundance, PYM was proposed to act as an NMD factor (Bono et al., 2004) . Recently, PYM was shown to interact with ribosomes and to cosediment with 40S ribosomal subunits in sucrose gradient centrifugations (Diem et al., 2007) . On the basis of this association, PYM was proposed to serve as a bridge between the EJC and the ribosome, and to mediate the stimulation of translation by EJCs bound within the ORF (Diem et al., 2007) .
Here, we show that PYM functions as an EJC disassembly factor. EJCs fully assembled by in vitro splicing are efficiently disassembled by PYM, but not by a mutant version of PYM that fails to directly interact with the MAGOH-Y14 heterodimer. Within cells, translation-independent disassembly of EJCs by PYM appears to be prevented by its stable association with ribosomes, which restricts the activity of PYM to mRNAs that are translated. Both overexpression and knockdown experiments demonstrate the in vivo role of PYM as an EJC disassembly factor, a function that is critical for posttranscriptional events such as NMD.
RESULTS

PYM Reduces the Amount of EJCs Bound to Spliced mRNAs
During the analysis of EJC assembly using in vitro splicing reactions, we noticed that two mutants of MAGOH designed to lack the interaction with PYM subtly but reproducibly coimmunoprecipitated more spliced MINX mRNA than wild-type (WT) MAGOH (N.H.G., S.L., M.W.H., and A.E.K., unpublished data). To confirm this observation, we utilized the three MAGOH mutants (E68R, E72R/D73K, and E117R) that lack binding to PYM (Figures 1A and 1B; N.H.G., S.L., M.W.H., and A.E.K., unpublished data) and quantified the amount of MINX mRNA that coprecipitates with these MAGOH mutants. Consistently, all three PYM bindingdeficient MAGOH mutants coprecipitate about twice as much MINX mRNA as WT MAGOH, despite comparable expression levels ( Figure 1C ). This result indicates that these MAGOH mutants either are more efficiently incorporated into EJCs, or that EJCs containing such mutants are more stable than EJCs with WT MAGOH. Both effects could be caused by the lack of PYM interaction, although alternative interpretations also exist. (A) Structure of MAGOH-Y14 and PYM as described in (Bono et al., 2004) . Mutated residues within MAGOH are indicated. The drawing was rendered using PyMOL (DeLano, 2002) with the structural data deposited in the protein data bank (ID: 1rk8). (B) Immunoprecipitations were done from RNase-A-treated lysates of HeLa cells that were transfected with FLAG-MAGOH, mutants of FLAG-MAGOH, or unfused FLAG as negative control together with V5-PYM and V5-Y14. Coprecipitated proteins were detected by immunoblotting using an anti-V5 antibody. (C) Splicing reactions in HeLa cell nuclear extract using MINX as substrate RNA were supplemented with 293 cell extracts expressing the indicated MAGOH mutants or unfused FLAG-tag as a negative control. Reactions were immunoprecipitated with FLAG affinity gel. Positions of the unspliced precursor transcript and the spliced product are displayed schematically. The bar diagram shows means and standard deviations (±SD) of three independent experiments. Abbreviations of MAGOH mutants used: 68, E68R; 72/73, E72R/D73K; 117, E117R. (D) Splicing reactions and immunoprecipitations were performed as above with the designated mutants of MAGOH. Where indicated, increasing amounts of recombinant PYM (rPYM) were added to the reactions.
To directly test if PYM is responsible for these observations, we purified recombinant PYM (rPYM) from bacterial expression cultures and added increasing amounts of rPYM to splicing reactions containing FLAG-MAGOH (see Experimental Procedures). Clearly, the addition of rPYM decreases the coimmunoprecipitation of MINX mRNA in a concentration-dependent manner ( Figure 1D, lanes 13 and 14) . This effect is highly specific and observed only when WT MAGOH, but not the MAGOH mutants 72/73 or 68 that lack the ability to interact with PYM, is used for immunoprecipitation ( Figure 1D , lanes [15] [16] [17] [18] [19] [20] . This result indicates that PYM selectively interferes with the stable association of EJCs with mRNAs in a process that involves a direct interaction with the MAGOH-Y14 heterodimer.
We next corroborated this result using other FLAG-tagged EJC proteins. Increasing amounts of rPYM were added to splicing reactions containing FLAG-eIF4A3, -BTZ, -MAGOH, -Y14, or -UPF3b, and we performed FLAG-immunoprecipitations. In all cases, rPYM strongly reduces the amount of coprecipitated MINX mRNA in a concentration-dependent manner ( Figure 2A) . Thus, the effect of rPYM is specific for EJCs but independent of the proteins used to precipitate the EJC. Importantly, the association of CBP80 with the mRNA is not inhibited by PYM under the same conditions ( Figure 2B ). Hence, PYM specifically targets mRNA-bound EJCs rather than nonspecifically disturbing mRNPs.
PYM interacts with the MAGOH-Y14 heterodimer via its N terminus (Bono et al., 2004) . We generated a deletion mutant of PYM ( Figure 2E ) lacking the N terminus to abolish its interaction with MAGOH-Y14. As expected, this mutant (PYM DN33) does not associate with MAGOH-Y14 in His-pull-down experiments using recombinant proteins ( Figure 2D ). When equal amounts of rPYM and rPYM DN33 are tested in splicing reactions, rPYM DN33 does not affect the amount of precipitated MINX mRNA, whereas rPYM reproduces the usual interference ( Figure 2C ). Thus, PYM requires its MAGOH-Y14-interacting N terminus to actively interrupt the association of the EJC with spliced mRNA. 
PYM Dissociates Assembled EJCs but Does Not Inhibit EJC Assembly
To determine whether PYM inhibits the assembly of stable EJCs or whether it disrupts assembled EJCs, we next utilized a splicing substrate that completes the first step of splicing but fails to undergo exon ligation (referred to as MINX GG; Reed and Maniatis, 1985) . The EJC proteins eIF4A3, MAGOH, and Y14 already associate with the splicing intermediate (C complex) that is formed on MINX GG (N.H.G., S.L., M.W.H., and A.E.K., unpublished data). Addition of rPYM does not affect the association of either of these three proteins with the pre-mRNA or with the C complex, and comparable amounts of splicing intermediates are immunoprecipitated, both in the presence and absence of rPYM ( Figure 3A) , although the protein is highly effective on fully spliced RNAs (Figures 2A and 2C ). This result indicates that PYM does not interfere with the EJC assembly intermediate that already includes its target, MAGOH-Y14. Rather, EJCs become sensitive to PYM at a later step, possibly when the spliceosome has dissociated from the mRNA.
If this hypothesis is correct and PYM has the ability to disassemble EJCs, it should be possible to dissociate EJCs from mRNAs after splicing is completed. We tested this notion by adding rPYM, or rPYM DN33 as a specificity control, to completed splicing reactions (120 min of splicing) and continued incubation for another 30 min. The addition of rPYM to completed splicing reactions decreases the amount of EJCs associated with the spliced MINX mRNAs, whereas rPYM DN33 has no effect ( Figure 3B ). These results demonstrate that PYM specifically disrupts mature EJCs, and that PYM is able to dissociate EJCs from spliced mRNAs. Of note, PYM cannot prevent the recruitment of MAGOH-Y14 by the spliceosome and the splicing-dependent first step of EJC assembly.
The exon junction complex is deposited 20 to 24 nucleotides upstream of exon-exon junctions on spliced mRNAs, resulting in protection of this region in an RNase H digestion assay (Le Hir et al., 2000) . Hence, the removal of EJCs by PYM should deprotect the EJC binding site. Indeed, addition of PYM to splicing reactions leads to an increased sensitivity of spliced MINX mRNA to oligonucleotide-mediated RNase H cleavage at the EJC binding position À24 in a concentration-dependent manner ( Figure 3C , empty arrowheads). Simultaneously, the generation of a diagnostic 3 0 cleavage fragment specifically from spliced mRNA is increased ( Figure 3C , filled arrowheads). This deprotection effect of PYM is not observed with PYM DN33. Thus, this experiment independently demonstrates that PYM removes EJCs that were properly located on spliced mRNAs.
PYM Does Not Stably Associate with EJCs or Spliced mRNAs PYM has been proposed to interact with the cytoplasmic EJC (cEJC) to recruit ribosomes to spliced mRNAs (Diem et al., 2007) and to represent a molecular link between the EJC and the stimulation of translation that was described for spliced mRNAs (Wiegand et al., 2003; Nott et al., 2004; Diem et al., 2007) . This raises the question of whether stable PYM-EJC complexes form.
To test whether PYM can detectably associate with EJCs deposited on spliced mRNAs, splicing reactions were supplemented with FLAG-PYM, mutants lacking the N or C terminus of PYM, or FLAG-MAGOH as a positive control. FLAG immunoprecipitations demonstrate that, compared with MAGOH, only trace amounts of PYM or its mutants associate with the spliced MINX mRNA ( Figure 3D ). Hence, the interaction of PYM with the RNA-bound EJC is inefficient by comparison to MAGOH, although a weak specific association can be observed (compare lanes 7-9 with lane 6). This association is splicing-dependent and not caused by a general RNA-binding activity of PYM (Bono et al., 2004) , because PYM binding to an unspliced mRNA does not exceed background levels under the same conditions ( Figure 3E ). These results show that PYM interacts only transiently or weakly with the EJC on a spliced mRNA substrate, and that it does not bind to RNA independently of the EJC. These data can be fully explained by PYM binding to the EJC as an intermediate in the context of disassembly.
The coimmunoprecipitation of PYM and EJC proteins with antibodies against both MAGOH and Y14 has been interpreted to show the EJC association of PYM (Diem et al., 2007) . Alternatively, these finding could reflect the existence of MAGOH-Y14 complexes with either PYM or as components of the EJC (Gehring et al., 2005; Chamieh et al., 2008) . To directly address this question, we analyzed the composition of complexes that are immunoprecipitated via PYM, MAGOH, or eIF4A3. PYM is associated only with MAGOH-Y14, whereas the other EJC proteins (BTZ, eIF4A3, UPF3b) are not detected in PYM immunoprecipitations ( Figure 3F ). In contrast, the EJC proteins BTZ and UPF3b are present in eIF4A3 immunoprecipitations, and correspondingly, BTZ, UPF3b, and eIF4A3 are found in MAGOH immunoprecipitations ( Figure 3F ). Similar results were obtained with endogenous PYM, MAGOH, Y14, and eIF4A3 ( Figure S2 , available online). Hence, the MAGOH-Y14 heterodimer exists in two mutually exclusive stable complexes, namely the EJC and the PYM complex. This analysis of complex composition at steady state is fully compatible with a transient interaction of PYM with the EJC to initiate its disassembly in the cytoplasm, and possibly to support EJC-mediated stimulation of translation (Diem et al., 2007) .
PYM Interferes with NMD In Vivo
Tethering of the EJC proteins MAGOH or Y14 to the 3 0 UTR of a reporter mRNA mimics NMD activated by a premature translation termination codon (Lykke- Andersen et al., 2001; Gehring et al., 2003) and, like NMD, requires mRNA translation and the NMD factor UPF1 (Lykke- Andersen et al., 2000; Gehring et al., 2005) . Furthermore, tethered MAGOH or Y14 absolutely requires interaction with its core EJC partners eIF4A3 and BTZ to trigger NMD: mutations that abolish these interactions abrogate MAGOH's and Y14's ability to trigger NMD in the tethering assay (Gehring et al., 2005) .
These observations provide the basis for a stringent functional assay to monitor the effect of PYM on EJC complexes in vivo. We tethered wild-type Y14, MAGOH, or the PYM interaction-defective MAGOH mutants 68, 72/73, and 117 to the 3 0 UTR of a reporter mRNA and evaluated the effect of increasing amounts of PYM on reporter mRNA levels. PYM strongly inhibits NMD mediated by tethered Y14 or WT MAGOH in a dose-dependent way ( Figure 4A , upper panel, lanes 2-7). Importantly, PYM does not affect the expression of the effector proteins Y14 and MAGOH ( Figure 4A , lower panel). Strikingly, tethering of the interaction-defective MAGOH mutants leads to NMD that is insensitive to coexpressed PYM (lanes 8-16). Thus, PYM interferes with NMD mediated by tethered Y14 or MAGOH in a highly specific way.
The finding that PYM dissociates EJCs generated by splicing in nuclear extracts and interferes with NMD in tethering assays in vivo suggests that the activity of PYM has to be controlled in living cells. Interestingly, PYM cosediments with the 40S ribosomal subunit and 48S preinitiation complexes through sucrose density gradients (Diem et al., 2007) . To determine the fraction of (A) Splicing reactions were performed using MINX GG as a substrate precursor RNA that does not undergo the second step of splicing. Immunoprecipitations were done via eIF4A3, Y14, and MAGOH. Reactions were supplemented with increasing amounts of rPYM as indicated. (B) Splicing reactions were performed using MINX as a splicing substrate for 2 hr in extracts supplemented with the indicated FLAG-proteins. After splicing was completed, recombinant PYM or PYM DN33 (gray shaded) was added and the reactions were incubated for another 30 min. Immunoprecipitations were done via eIF4A3 or Y14. (C) Splicing reactions were performed with MINX Di (lanes 1 and 2) or MINX (lanes 3-10). After 2 hr the splicing extracts were supplemented with a DNA oligonucleotide complementary to the EJC deposition site 24 nucleotides upstream of the exon-exon junctions to activate RNase H digestion. The ''diagnostic'' fully spliced product and the 3 0 fragment of the RNase H digestion, which correlate with the amount of protection, are indicated by arrowheads. A shorter exposure of the fully spliced product is shown on the bottom. The bar diagram displays means ± SD of the amount of fully spliced MINX or MINX Di obtained from three independent experiments.
(D) Splicing reactions were done in extracts supplemented with FLAG-PYM, FLAG-tagged mutants of PYM, or FLAG-MAGOH. Bottom panel: Expression of FLAG-proteins (anti-FLAG antibody).
(E) MINX Di transcript was incubated under splicing conditions in extracts supplemented with the set of proteins described in (D).
(F) Immunoprecipitations were done from RNase-A-treated lysates of 293 cells that were transfected with FLAG-PYM, FLAG-MAGOH, FLAG-eIF4A3, or unfused FLAG as negative control together with V5-tagged BTZ, UPF3b, eIF4A3, PYM, Y14, and MAGOH. Coprecipitated proteins were detected by immunoblotting using an antibody to V5.
PYM that is associated with ribosomes in HeLa cells, we pelleted ribosomes by ultracentrifugation (200,000 3 g) and assessed the distribution of PYM between the ribosomal pellet and the postribosomal supernatant. Remarkably, PYM preferentially cosediments with ribosomes, rendering the postribosomal supernatant almost devoid of PYM ( Figure 4B ). The ribosomal association of PYM was confirmed by coimmunoprecipitation of two ribosomal proteins (RPS6 and RPL23) ( Figure 4C ). The ribosome association of PYM appears to be mediated via its C terminus (Diem et al., 2007) . We generated a PYM mutant lacking this region (PYM DC53) and analyzed its ribosomal association. At low concentrations of transfected WT PYM (tagged Northern blot analysis of RNA from HeLa cells that were transfected with expression plasmids for lNV5-tagged Y14, MAGOH, or mutants of MAGOH together with the 4boxB reporter plasmid and the transfection control plasmid. PYM was cotransfected where indicated. The numbers indicate changes in mRNA abundance and standard error of the mean (±SEM) determined by analysis of three independent experiments. Lower panel: Expression levels of FLAG-PYM and the tethered proteins were detected by immunoblot analysis with FLAG-and V5-specific antibodies, respectively. GFP served as a loading control. (B) HeLa cell lysates were subjected to ultracentrifugation to pellet ribosomes. Endogenous PYM, the ribosomal proteins RPL23 and RPS6, and the soluble cytosolic protein UAP56 were detected in the input, postribosomal supernatant and ribosomal pellet fractions by immunoblotting with specific antibodies. (C) Immunoprecipitations were done from RNase-A-treated lysates of HeLa cells that were transfected with FLAG-PYM or unfused FLAG as negative control. Coprecipitated proteins were detected by immunoblotting using RPS6 and RPL23 antibodies, and FLAG-PYM was detected with a FLAG antibody. (D) HeLa cells were transfected with Venus-PYM, Venus-PYM DC53, or unfused Venus. Ribosomes were pelleted as in (B), and Venus and Venus fusion proteins were detected with a GFP antibody. (E) Northern blot analysis of RNA from HeLa cells that were transfected with the NMD reporter plasmids b-globin WT or NS39 and the transfection efficiency control. Cotransfection of PYM, PYM DC53, or Y14 is indicated (1 or 2 mg per transfection). The percentages indicate changes in mRNA abundance ± SEM determined by analysis of six independent experiments. Bottom panel: Expression levels of FLAG-PYM and FLAG-Y14 were detected by immunoblot analysis with a FLAG-specific antibody. GFP served as a loading control. with Venus) and tagged PYM DC53, the WT protein acts like endogenous PYM and quantitatively pellets with ribosomes ( Figure 4D , ''low''). By contrast, the majority of PYM DC53 is found in the supernatant, confirming the importance of the C-terminal domain for ribosome binding (Diem et al., 2007) . At higher concentrations of transfected protein ( Figure 4D , ''high'') the fraction of WT PYM in the supernatant increases and PYM DC53 is abundantly soluble in the cytoplasm.
To test whether PYM also interferes with physiological (nontethered) NMD, we tested two well-characterized NMD model substrates: b-globin NS39 mRNA (Thermann et al., 1998; Zhang et al., 1998) and T cell receptor beta (TCR-b) NS98 mRNA (Wang et al., 2002) . Increasing amounts of PYM were cotransfected with b-globin NS39 ( Figure 4E ) and TCR-b NS98 ( Figure 4F ) reporters. Strikingly, overexpression of PYM causes increased accumulation of the nonsense-containing b-globin NS39 mRNA ( Figure 4E ), while the wild-type b-globin mRNA remains unaffected. This NMD inhibition is even more pronounced with PYM DC53 that is not restricted by ribosome binding ( Figure 4E ). The overexpression of Y14 to similar amounts as PYM does not alter NMD efficiency, demonstrating the specificity of the effect. Similar results were obtained for the TCR-b NS98 NMD substrate ( Figure 4F ), indicating the generality of these findings. We conclude that PYM interferes with NMD in vivo and suggest that the ribosome association of PYM might help to prevent detrimental random disassembly of EJCs.
PYM Disassembles EJCs in Living Cells
Finally, we wanted to investigate directly whether PYM disassembles EJCs in living cells and test whether the number of EJCs associated with spliced mRNAs is diminished in cells overexpressing PYM or PYM DC53. As a specificity control, we employed PYM DN33 that is not expected to affect EJC association (Figure 2 ). Because EJCs preferentially associate with newly transcribed and spliced mRNAs, we used a tetracycline-responsive b-globin expression plasmid in Tet-Off HeLa cells. Following a protocol that was previously established to assess the association of human UPF proteins with spliced mRNAs (Lykke- Andersen et al., 2000) , translation was inhibited by adding cycloheximide to the cells for the final 3 hours to block removal of EJCs by translation. Extracts from cells transfected with FLAG-Y14 and PYM, PYM DC53, PYM DN33, or an additional empty vector control were subjected to FLAG-immunoprecipitation followed by quantitative real-time polymerase chain reaction (qRT-PCR) for b-globin mRNA.
The result shown in Figure 5A demonstrates that the interaction of the EJC protein Y14 with spliced b-globin mRNA is strongly reduced when PYM or PYM DC53 (but not PYM DN33) is overexpressed. This result directly demonstrates that PYM can disassemble EJCs from spliced mRNAs in living cells. To further test the specificity of overexpressed PYM, we conducted a similar experiment using FLAG-MAGOH instead of FLAG-Y14, including two mutants of MAGOH deficient in PYM binding (72/73 and 117). Although EJCs that contain MAGOH WT protein are disassembled by PYM DC53 (and not PYM DN33), EJCs containing the PYM binding-deficient mutants of MAGOH are resistant to disassembly ( Figure 5C ). This result also demonstrates that the direct interaction of PYM with its target proteins MAGOH and Y14 is required to disassemble EJCs in vivo.
To complement our in vitro analyses ( Figure 3F ), we analyzed the interactions between the core EJC proteins eIF4A3, Y14, and MAGOH in cells expressing PYM, PYM DC53, or PYM DN33. Our previous results suggest that PYM DC53 should disrupt the interaction of the MAGOH-Y14 heterodimer with eIF4A3. Strikingly, PYM DC53 not only strongly reduces the association of EJCs with spliced RNAs, but also diminishes the amount of eIF4A3 that coprecipitates with FLAG-Y14 ( Figure 5E ), while the association between MAGOH and Y14 is unaffected ( Figure 5E ); PYM DN33 shows no effect ( Figure 5E ). Hence, EJC disassembly by PYM in vivo is also observed at the protein level, supporting the RNA data.
To answer the question of whether PYM removes EJCs from nontranslated mRNAs, we tested EJC disassembly from U22HG and Gas5 RNAs that have multiple introns containing snoRNAs, but lack long ORFs (Tycowski et al., 1996; Smith and Steitz, 1998; Ideue et al., 2007) . Using the EJC immunoprecipitation assay from cell lysates, we find that overexpressed PYM and PYM DC53 decrease U22HG and Gas5 RNA association with FLAG-Y14, suggesting that PYM can disassemble EJCs located outside of ORFs and confirming a more general function of PYM as an EJC disassembly factor.
To assess if PYM is required for EJC disassembly in living cells, we depleted PYM using two different small-interfering RNAs (siRNAs) ( Figure 6A ) and quantified EJC association with U22HG, Gas5, or b-globin RNAs without blocking translation. PYM deficiency consistently causes increased EJC association with all three RNAs ( Figure 6B ). Interestingly, this effect is more pronounced with U22HG and Gas5 RNAs, suggesting that ribosomes that translate the b-globin mRNA contribute to EJC removal even when PYM levels are diminished, albeit less efficiently than with normal cellular PYM levels.
If PYM is required for the efficient removal of EJCs from mRNAs in the cytoplasm, then we reasoned that in cells lacking PYM, components of the EJC should accumulate in the cytoplasm, representing the increased levels of EJCs that are not disassembled. To deplete endogenous PYM levels even more efficiently than with the RNAi approach, we transfected HeLa cells first with morpholino oligonucleotides targeting PYM, and then with a mixture of the previously identified siRNAs. PYM protein was undetectable in cells treated according to this protocol ( Figure 6D ). As hypothesized, we found increased cytoplasmic levels of the EJC proteins eIF4A3, Y14, and MAGOH in cells lacking PYM ( Figure 6D ). We also detected a corresponding decrease of nuclear Y14 and MAGOH, while the amount of nuclear eIF4A3 was not noticeably changed. In summary, our data establish that the disassembly of EJCs is disturbed in PYM-deficient cells.
DISCUSSION
Exon junction complexes are assembled during splicing, accompany the mRNA during nuclear export into the cytoplasm, and serve as architectural landmarks of the exon-intron structure of genes until their removal during translation. EJC removal has been assumed to be an inherent activity of ribosomes resulting 
PYM Disassembles EJCs in Living Cells
(A) HeLa Tet-Off cells were transfected with a Tet-responsive b-globin plasmid together with plasmids for V5 (empty vector), V5-PYM, V5-PYM DC53, or V5-PYM DN33 and FLAG or FLAG-Y14 as indicated. b-globin transcription was induced by replacing the tetracycline-containing with tetracycline-free medium. Cells were lysed and FLAG-containing complexes were immunoprecipitated. RNA was extracted and b-globin mRNA was quantified in the immunoprecipitations using quantitative RT-PCR. The bar diagram displays the means ± SEM of four independent experiments. (B) Representative immunoblot of protein loads that were used for the immunoprecipitations shown in (A). (C) Cells were transfected and treated as described in (A) except that MAGOH WT, MAGOH 117 or MAGOH 72/73 were used instead of Y14. Bar diagrams display means ± SEM of three independent experiments. DC53-and DN33-transfected samples were normalized to V5-transfected samples (100%). (D) Representative immunoblot of protein loads that were used for the immunoprecipitations shown in (C). (E) FLAG-immunoprecipitation analysis of RNase A-treated lysates from cells that were transfected as described in (A). Endogenous MAGOH and eIF4A3 were detected with specific antibodies, FLAG-Y14 and V5-PYM were detected with FLAG or V5 antibodies, respectively. (F) HeLa Tet-Off cells were transfected with plasmids encoding V5, V5-PYM, V5-PYM DC53 or V5-PYM DN33 and FLAG or FLAG-Y14. Cells were lysed and FLAG-containing complexes were immunoprecipitated. RNA was extracted and U22HG mRNA was quantified in the IP's using RT-PCR. The bar diagram displays the means ± SEM of four independent experiments. (G) FLAG-complexes were immunoprecipitated from HeLa Tet-Off cells that were transfected and lysed and as described in (F). Gas5 mRNA was quantified as in (F).
from their processivity during initiation and elongation (Dostie and Dreyfuss, 2002) . Here, we identify PYM as an active, ribosome-associated EJC disassembly factor in mammalian cells and characterize its mode of function. We show that excess ''free'' PYM disassembles EJCs in living cells and thus inhibits NMD. These results have far-reaching implications for EJC turnover, translation, and NMD (Figure 7 ).
PYM-Mediated Disassembly of Mature but Not Maturing EJCs
PYM has been crystallized as part of a heterotrimeric complex with the EJC proteins MAGOH-Y14 (Bono et al., 2004) . Tethered PYM was reported to mediate NMD (Bono et al., 2004) , suggesting that PYM associates with the EJC to support its functions.
However, we noticed that the binding of EJCs to spliced mRNAs is augmented with mutants of MAGOH that cannot bind PYM (Figure 1 ). This observation suggested that PYM antagonizes EJC assembly and/or stability and prompted detailed biochemical and functional analyses.
Remarkably, PYM does not interfere with the assembly of MAGOH-Y14 into EJC complexes by the spliceosome, but specifically disrupts mature EJCs after release of the spliceosome from the mRNA (Figures 2 and 3 ). This activity requires direct protein-protein interactions between MAGOH and the N terminus of PYM (Figures 1-3) . Stable binding of PYM to MAGOH-Y14 would not be possible within the EJC, because residues of PYM would clash with residues of eIF4A3 (Bono et al., 2006) , suggesting that stable PYM-EJC assemblies should (lanes 1-4) or PYM siRNAs (lanes 5 and 6) with a PYM antibody. Dilutions corresponding to 50%, 20%, or 10% (lanes 2-4) of the initial protein amount (lane 1) from negative control-siRNA-transfected cells were loaded to assess the efficiency of the PYM depletion. Reprobing with a tubulin-specific antibody was performed to control for loading. (B) HeLa Tet-Off cells were transfected with negative control siRNAs (neg) or siRNAs targeting PYM (siPYM 1 and siPYM 2). Thirty-two hours later cells were transfected with a Tet-responsive b-globin plasmid and FLAG or FLAG-Y14 as indicated. b-globin transcription was induced by replacing the tetracyclinecontaining with tetracycline-free medium. Cells were lysed and FLAG-containing complexes were immunoprecipitated. RNA was extracted and U22HG, Gas5 and b-globin mRNA was quantified in the IP's using quantitative real time PCR. The bar diagram displays the means ± SEM of five independent experiments. (C) Representative immunoblot of protein loads that were used for the immunoprecipitations shown in (B). (D) HeLa cells were transfected with morpholino antisense oligonucleotides targeting PYM (lanes 2 and 4) or corresponding negative control morpholino oligonucleotides (lanes 1 and 3) and negative control siRNAs (lanes 1 and 3) or a mix of the two PYM targeting siRNAs (lanes 2 and 4). Cells were harvested and nucleoand cytoplasmic fractions isolated. Y14, MAGOH, eIF4A3, lamin A, tubulin, and UAP56 were detected by western blotting with specific antibodies in the nuclear (20 mg protein) and cytoplasmic (30 mg) fractions. The separation of nuclear and cytoplasmic fractions was efficient as judged by the distribution of cytoplasmic tubulin and the nuclear proteins lamin A and UAP56. The depletion efficiency of PYM was determined in the cytoplasmic fraction. The asterisk denotes an unspecific cross-reactive band observed with the PYM antibody under these conditions. not exist. This prediction was confirmed in vitro and in vivo (Figures 3, 5 , and S2): Consistent with the results of Chamieh et al. (2008) , the MAGOH-Y14 heterodimer appears to form mutually exclusive, stable complexes with either PYM or within the EJC.
These findings raise the questions of why EJC assembly intermediates including MAGOH-Y14 are ''immune'' to PYM, and how PYM initiates the disassembly of mature EJCs. The insensitivity of maturing EJC assembly intermediates to PYM might have different causes. First, spliceosomal proteins might protect MAGOH-Y14 from PYM during EJC assembly. This would involve interactions of MAGOH-Y14 with the spliceosome during the deposition of the EJC on the RNA. Second, after the release of the spliceosome, MAGOH-Y14 heterodimers might undergo conformational changes that enable their interaction with PYM, or the PYM interaction might be helped by an EJC protein that is still lacking from the minimal EJC core after the first step of splicing. Furthermore, PYM is a largely cytosolic protein that further protects nascent EJCs from PYM-mediated disassembly.
How does PYM trigger disassembly of EJCs in the cytoplasm? Based on available structural and biochemical data (Bono et al., 2004 (Bono et al., , 2006 Gehring et al., 2005; Andersen et al., 2006; Chamieh et al., 2008; Nielsen et al., 2009) , we suggest that the interaction of PYM with solvent-accessible side chains of MAGOH-Y14 within the mature EJC leads to the formation of a transient intermediate that destabilizes MAGOH-Y14 from the EJC. As a consequence, the lock imposed by MAGOH-Y14 on eIF4A3 imposed by MAGOH-Y14 is removed, and ADP, inorganic phosphate, and the RNA are released (Nielsen et al., 2009 Exon junction complexes are assembled during splicing in the nucleus. The EJC structure was rendered using PyMOL (DeLano, 2002) with structural data deposited in the protein data bank (ID: 2j0s). PYM (yellow) interacts via its C terminus (indicated by C) with the small ribosomal subunit and removes EJCs during ribosomal transit via interaction of its N terminus (N) with MAGOH-Y14. Cytosolic ''free'' PYM is minimized by its ribosomal association, because ''free'' PYM can dismantle EJCs independently of translation. Disassembled EJC components are recycled and transported back to the nucleus. On encountering a premature translation termination codon (PTC), downstream EJCs are recognized and NMD is activated (not shown).
furthermore prevented by the formation of trimeric PYM-MAGOH-Y14 complexes. It will be interesting to investigate whether PYM suffices to disassemble EJCs that have been assembled from recombinant subunits, or whether PYM requires cofactors that are present in splicing extracts. Similarly, it will be informative to explore whether cytoplasmic proteins exist that can protect the EJC from disassembly by PYM.
Functional Implications of EJC Disassembly by PYM for EJC Recycling and NMD Translation and EJC removal have previously been proposed to be coupled (Dostie and Dreyfuss, 2002; Lejeune et al., 2002) , but the mechanism of EJC removal has remained enigmatic and been attributed to ribosomal processivity (Dostie and Dreyfuss, 2002) . Based on both overexpression and loss-of-function (''knock-down'') analysis, this work establishes PYM as an EJC disassembly factor in living cells.
Discrimination of WT mammalian mRNAs from those bearing premature termination codons involves the translation-dependent assessment of the position of the stop codon relative to the last EJC: messenger RNAs that retain an EJC downstream from the stop codon are considered ''faulty'' and degraded by NMD (Thermann et al., 1998) . Hence, coupling of EJC disassembly to mRNA translation appears logical because it ensures (1) that EJCs are only removed from mRNAs that have undergone at least one round of translation and (2) that EJCs are only removed from positions within the ORF but not from positions sufficiently far downstream of (premature) translation termination codons.
These two criteria would be met if the ribosome itself was the sole EJC disassembly machine, but not if EJC disassembly is catalyzed by a soluble cytoplasmic protein that could remove EJCs irrespective of mRNA translation and EJC position within the mRNA. We propose that the binding of PYM to the ribosome ( Figures 4B and 4D ) serves to couple bulk EJC removal by PYM to translation, and hence to protect proper NMD function. Indeed, accumulation of ''free'' cytosolic PYM inhibits NMD of classical NMD substrates (Figure 4 ) and in tethering assays ( Figure 4A ).
Knock down of PYM reveals two interesting aspects. First, spliced (m)RNAs lacking an ORF accumulate EJCs when PYM levels are diminished ( Figure 6B) ; hence, an appropriate low level of free PYM might serve the physiological role of EJC removal from RNAs such as U22HG and Gas5. Second, EJC association with b-globin mRNA is also increased in PYM-deficient compared with wild-type cells, but less so than with the U22HG and Gas5 RNAs. This result indicates that the ribosome is able to dissociate EJCs without the help of PYM (unless the residual levels of PYM are essential), but that PYM contributes to EJC removal from translated mRNAs.
We have determined that HeLa cells express far fewer molecules of PYM than the number of ribosomes per cell ( Figure S1 ). This raises the interesting question of how PYM associates preferentially with the ribosomes that execute (the first round of) translation, or how ribosomes bound by PYM are preferentially selected for translation. It is presently unknown how PYM binds to the ribosome, and it might do so indirectly in a way that requires the association of translation (initiation) factors with the ribosome. Such a requirement would recruit PYM only to ribosomes that are translationally active and could also explain why overexpression of PYM leads to the accumulation of free cytosolic PYM despite the high abundance of ribosomes (Figure 4) . PYM has also recently been implicated in the process of translation stimulation by EJCs (Diem et al., 2007) ; such a mechanism could help ensure that the translation of mRNAs with EJCs is executed by ribosomes bound by PYM.
The number of approximately 400,000 exon-exon junctions within the steady-state transcriptome of HeLa cells (100,000 transcripts with a mean of 4 introns; Jackson et al., 1998; Deutsch and Long, 1999) far exceeds the abundance of EJC subunits per cell (10,000 for eIF4A3 and 40,000 for Y14 and MAGOH, respectively; see Figure S1 ). Thus, newly exported mRNAs bearing EJCs must be preferentially translated, and their EJC components efficiently disassembled and recycled. PYM might represent the keystone that encapsulates both needs: it might help to direct translation preferentially to EJC-bound mRNAs (Le Hir et al., 2003; Wiegand et al., 2003; Nott et al., 2004; Diem et al., 2007) , and mediate efficient EJC disassembly and recycling. Future studies will address the pathway(s) along which the EJC subunits recycle into the nucleus.
EXPERIMENTAL PROCEDURES Plasmids
Plasmids b-globin WT, -NS 39, -4boxB, pCI-lNV5, pCI-FLAG, pCI-V5, the transfection control (WT300+e3), and expression vectors for Y14, MAGOH, eIF4A3, BTZ, and UPF3b were all described previously (Gehring et al., 2003 (Gehring et al., , 2005 . pCI-Venus was generated from pCl-GFP by site-directed mutagenesis. Full-length PYM and CBP80 cDNAs were obtained by RT-PCR using total HeLa cell RNA and inserted into pCI-neo FLAG. TCR-b WT and NS98 expression plasmids (b290 and b595; Wang et al., 2002) were kindly provided by Miles Wilkinson and Wai-Kin Chan. The TCR-b ORF was PCR amplified and cloned into pCI-neo. Mutants of MAGOH were described previously (Gehring et al., 2005) or generated by PCR, and mutants of PYM were generated by PCR. MINX (Bell et al., 2002) was cloned into pGEM4. MINX GG and MINX Di were generated by PCR mutagenesis and inserted into pGEM4. All constructs were verified by DNA sequencing.
Cell Culture and Transfections
HeLa, HeLa Tet-Off, and HEK293 MSR ''GripTite'' cells were grown and transfected with plasmid DNA according to standard procedures (Gehring et al., 2005) . For tethering experiments, 0.8 mg lNV5-fusion construct, 0.5 mg control plasmid (WT300+e3), 2 mg 4boxB reporter vector, and 0.2 mg GFP expression plasmid were transfected using six-well plates. For transfections of b-globin WT or NS39, we used 1 mg pCI-WT or NS39, 0.5 mg control plasmid, and 0.3 mg GFP expression vector. Transfections for immunoprecipitations were done in 10 cm dishes with 3-4 mg FLAG-expression plasmid and 1 mg GFPand 0.8 mg V5-expression plasmids. GripTite 293 MSR cells (Invitrogen) were transfected with 6 mg FLAG expression plasmids and 2 mg GFP expression vector in 10 cm dishes.
RNA Extraction and Analysis
Total cytoplasmic or total RNA were analyzed by northern blotting (Gehring et al., 2003) . Signals were quantified in a FLA-3000 fluorescent image analyzer (Raytest). Percentages were calculated as described elsewhere (Gehring et al., 2003 (Gehring et al., , 2005 .
Protein Extraction, Nucleocytoplasmic Fractionation, Immunoblot Analysis, and Immunoprecipitation For immunoblot analysis, 10-15 mg cytoplasmic extracts were subjected to SDS-PAGE. Complexes of FLAG-tagged proteins were immunoprecipitated using FLAG-M2 affinity gel (Sigma) from RNase A-treated (20 mg/ml) lysates (Gehring et al., 2003) . Nuclear and cytoplasmic fractions were prepared using the NE-PER kit (Pierce).
In Vitro Transcription, In Vitro Splicing, and RNP Immunoprecipitation Capped pre-mRNA transcripts were generated by in vitro transcription with SP6 RNA polymerase in the presence of m7GpppG cap analog. In vitro splicing reactions were performed for 2 hr in HeLa nuclear extract (CIL Biotech) that was supplemented with whole-cell extracts from 293 cells transfected with different FLAG-tagged EJC proteins (Kataoka and Dreyfuss, 2004) . A total of 293 whole-cell extracts were prepared as previously described (Kataoka and Dreyfuss, 2004) . FLAG-immunoprecipitations of RNPs were performed with FLAG-M2 affinity gel in mRNP IP buffer (20 mM HEPES KOH [pH 7.9], 200 mM NaCl, 2 mM MgCl 2 , 0.2% Triton X-100, 0.1% NP-40, 0.05% Na-deoxycholate). RNAs were recovered by TRI reagent extraction and isopropanol precipitation. RNA was analyzed by denaturing PAGE.
For RNase H digestions, MINX or MINX Di transcripts were incubated under splicing conditions for 2 hr. RNase H was activated by adding a cDNA oligo (1 mM) complementary to the À24 position to the splicing reactions and incubating for 15 min. RNAs were extracted and analyzed as described above. Signals were quantified on a Phosphoimager.
Y14-and MAGOH-RNA Coimmunoprecipitations and Quantitative
Real-Time RNA Analysis HeLa Tet-Off cells (Clontech) were transfected in 10 cm dishes with 6 mg pTRE Tight b-globin, 7.5 mg pCI-V5, pCI-V5 PYM DC53 or pCI-V5 PYM DN33, and 4 mg pCI-FLAG, pCI-FLAG-Y14, or pCI-FLAG MAGOH using calcium phosphate precipitation. Forty hours after transfection, the tetracycline-containing medium was replaced by tetracycline-free medium, and 2 hr later cycloheximide (only Figures 5A-5D ) was added (100 mg/ml) and cells were incubated for an additional 3 hr. Cells were lysed in mRNP IP buffer (20 mM HEPES KOH [pH 7.9], 200 mM NaCl, 2 mM MgCl 2 , 0.2% Triton X-100, 0.1% NP-40, 0.05% Na-deoxycholate) on ice. Cleared lysates were used for FLAG-immunoprecipitation for 1-2 hr at 4 C. The FLAG-affinity gel was washed four times with mRNP IP buffer and FLAG-tagged proteins were eluted with TRI-reagent. Total RNA was prepared from the input and eluted fractions. Quantitative RT-PCR (LightCycler) measuring SYBR Green incorporation was used to quantify relative b-globin, U22HG, and Gas5 mRNA levels. Primer sequences were 5 0 -TATCATGCCTCTTTGCACCA-3 0 and 5 0 -AATCCAGCCTTATCCCAA CC-3 0 (globin); 5 0 -GATTCATGGCACCCAGACTT-3 0 and 5 0 -TAAAGGCTCATG ACGGGAAC-3 0 (U22HG); 5 0 -GGTATGGAGAGTCGGCTTGA-3 0 and 5 0 -GCAC TCTAGCTTGGGTGAGG-3 0 (Gas5).
siRNA and Morpholino Oligo Transfection
HeLa and HeLa Tet-Off cells were transfected with siRNAs as previously described (Gehring et al., 2003) . siRNAs (siPYM 1 and 2) were purchased from Ambion (silencer select siRNA), the ''Silencer Select Negative Control #1 siRNA'' was used as control (neg). Morpholino antisense oligonucleotides targeting the PYM initiation codon and a PYM pre-mRNA splice site were purchased from Gene Tools. Reversed morpholino oligos served as negative controls. Morpholino oligos were transfected using Endo-Porter peptide in dimethyl sulfoxide according to the manufacturer's recommendations. HeLa cells were reseeded at the appropriate density 1 day after they were transfected with morpholino oligos for subsequent siRNA transfections.
